Highlights
News & International Events
Highlights
News & International Events
Highlights
News & International Events
News
Biodentine XP awarded Product of the Year 2024
We are proud to announce that Biodentine XP has been nominated as the Product of the Year 2024 at the most significant dental congress in France and a leading dental scientific event in Europe - ADF Congress.
Septodont publishes its first Engagement Report
We are pleased to announce the publication of Septodont’s first Engagement Report, which reflects our long-standing commitments to corporate social responsibility and engagement toward building a sustainable future. This report showcases our achievements, challenges, and progress in making a positive impact for our clients, our patients, our partners and our employees.
Moderna and Septodont’s pharma division announce long-term agreement
Moderna, the biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Septodont’s pharma division, Novocol Pharma, announced a long-term agreement to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines.
R.T.R.+ Membrane: the new resorbable bilayer synthetic membrane
Septodont is happy to introduce today R.T.R.+ Membrane, the unique resorbable synthetic membrane designed to improve post-extraction procedures.
Septodont announces collaboration with Immersify Education
Septodont, the world leader in dental pain management and proprietary of the Active Biosilicate Technology with Biodentine and BioRoot, is happy to announce its collaboration with Immersify Education.
Septodont strenghtens its commitment to the employment of people with disabilities
Septodont has been developing a diversity policy and more specifically a disability and employment policy aiming at enabling people with disabilities to have equal access to employment opportunities and career development.
Septodont Wins BFM Business Grand Prize for Mid-Sized Companies
The French business news channel, BFM Business, hosted on September 26th its annual Grand Prize award ceremony for mid-sized companies (“Les Grands Prix BFM Business des ETI”) and we are delighted to announce that Septodont has won the Grand Prize in the International category.
Septodont Acquires Biomedical Tissues
We are delighted to announce that Septodont has completed the acquisition of Biomedical Tissues (BMT), a French MedTech company at the forefront of tissue engineering. The company designs, produces and commercializes implantable membranes for tissue regeneration.
International Events
Major international events where Septodont will have an active presence.